Reem Karmali - Concepedia

Author

Reem Karmali

Also Known As

Barta, Stefan K, Bartlett, Nancy L., Jesme, Christy, Karmali R, Karmali, Reem, Leo I. Gordon, R Karmali, R. Karmali, Reem Karmali, Steinberg, Amir

357

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Northwestern University The Ohio State University Emory University Roswell Park Comprehensive Cancer Center Rush University Medical Center

About

Reem Karmali is an author at Northwestern University specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.1K
2	Health Sciences	10	10	432
3	Cellular Therapies	2	2	126
4	Public Health	1	1	22
5	Cell Biology	1	1	11

Reem Karmali

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis Adam M. Petrich, Mitul Gandhi, Borko Jovanovic, Blood	2014	461
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis Nilanjan Ghosh, Reem Karmali, Vanderson Rocha, Journal of Clinical Oncology	2016	227
A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Blood	2011	158
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial Catherine Diefenbach, Fangxin Hong, Richard F. Ambinder, The Lancet Haematology Phase 1/2Lymphoid NeoplasiaOncologyRefractory Hodgkin LymphomaClinical Trials	2020	137
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma Pamela B. Allen, Hatice Savas, Andrew M. Evens, Blood	2020	135
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh, Blood	2021	122
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba, Nature Medicine	2024	106
Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome Chadi Nabhan, Sonali M. Smith, Irene Helenowski, British Journal of Haematology Lymphoid NeoplasiaGeriatric OncologyAgingGeriatricsMedicine	2011	94
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era James N. Gerson, Elizabeth A. Handorf, Diego Villa, Journal of Clinical Oncology	2019	94
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook, Blood	2021	91

Page 1